Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.38 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.36 |
| ▸ | ADK | P55263 | 1/20 | 0.33 |
| ▸ | LIMK1 | P53667 | 2/20 | 0.32 |
| ▸ | PRKDC | P78527 | 3/20 | 0.31 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.31 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.31 |
| ▸ | GPR3 | P46089 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.31 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.30 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.30 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18089928 | 0.99 | PARP14 (0.38) | ALOX5PARP14ADKLIMK1PRKDC | |
| SCHEMBL18090131 | 0.93 | ALOX5 (0.35) | ALOX5PARP14ADKPRKDCPIK3CD | |
| SCHEMBL18090132 | 0.92 | PARP14 (0.35) | ALOX5PARP14ADKPRKDCPIK3CD | |
| SCHEMBL18090001 | 0.91 | PRKDC (0.37) | ALOX5PARP14ADKPRKDCPIK3CD | |
| SCHEMBL18090104 | 0.89 | PRKDC (0.32) | ALOX5ADKPRKDCPIK3CDPIK3CB | |
| SCHEMBL18089911 | 0.87 | PARP14 (0.45) | ALOX5PARP14LIMK1PRKDCPIK3CD | |
| SCHEMBL18089929 | 0.87 | PARP14 (0.38) | ALOX5PARP14ADKLIMK1PRKDC | |
| SCHEMBL18089997 | 0.86 | PRKDC (0.39) | ALOX5PARP14ADKPRKDCPIK3CD | |
| SCHEMBL17754690 | 0.86 | ALOX5 (0.43) | ALOX5PARP14LIMK1PRKDC | |
| SCHEMBL22410281 | 0.85 | ALOX5 (0.34) | ALOX5PARP14LIMK1GPR3CDK5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9780316-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2017-10-03 | — | — | US | disclosed |
| US-9780316-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2017-10-03 | — | — | US | disclosed |
| US-20160276604-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2016-09-22 | — | — | US | disclosed |
| US-20160276604-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2016-09-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160276604-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | RB1, LEF1, BRD1 | ALOX5 551/4885PARP14 1293/4885ADK 2972/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.